Stem Cell Research (May 2019)

Generation of induced pluripotent stem cells (IBMSi011-A) from a patient with Parkinson's disease carrying LRRK2 p.I1371V mutation

  • Han-I Lin,
  • Yu-Che Cheng,
  • Hui-Wen Ko,
  • Cheng-Hao Wen,
  • Huai-En Lu,
  • Ching-Ying Huang,
  • Patrick C.H. Hsieh,
  • Chin-Hsien Lin

Journal volume & issue
Vol. 37

Abstract

Read online

Leucine rich repeat kinase 2 (LRRK2) is the causative gene for autosomal-dominant familial forms of Parkinson's disease (PD). Here, we generated induced pluripotent stem cells (iPSCs) from the peripheral blood mononuclear cells of a female patient with LRRK2 c.4111A > G (p.I1371V) mutation by using the Sendai-virus delivery system. The resulting iPSCs had a normal karyotype. The iPSCs also showed pluripotency confirmed by immunofluorescent staining and differentiated into the three germ layers in vivo. This cellular model will provide a platform for studying the role of LRRK2 in the disease process.